Clinical Trial Update: Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating epoetin alfa for treating chemotherapy-induced anemia in cancer patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Leukemia
• Lymphoma
• Lymphoproliferative Disorder
• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Anemia, Leukemia | Phase 2 | Status: COMPLETED